Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.070
-0.060 (-2.82%)
At close: May 12, 2025, 4:00 PM
2.070
0.00 (0.00%)
After-hours: May 12, 2025, 8:00 PM EDT
Stereotaxis Revenue
In the year 2024, Stereotaxis had annual revenue of $26.92M with 0.55% growth. Stereotaxis had revenue of $6.34M in the quarter ending December 31, 2024, with 38.88% growth.
Revenue (ttm)
$26.92M
Revenue Growth
+0.55%
P/S Ratio
6.55
Revenue / Employee
$193,655
Employees
139
Market Cap
177.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.92M | 147.00K | 0.55% |
| Dec 31, 2023 | 26.77M | -1.38M | -4.89% |
| Dec 31, 2022 | 28.15M | -6.87M | -19.63% |
| Dec 31, 2021 | 35.02M | 8.39M | 31.51% |
| Dec 31, 2020 | 26.63M | -2.27M | -7.86% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
STXS News
- 1 hour ago - Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 hours ago - Stereotaxis Reports 2025 First Quarter Financial Results - GlobeNewsWire
- 20 days ago - Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025 - GlobeNewsWire
- 21 days ago - Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025 - GlobeNewsWire
- 7 weeks ago - Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program - GlobeNewsWire
- 2 months ago - Stereotaxis to Present at 37th Annual Roth Conference - GlobeNewsWire
- 2 months ago - Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn - Seeking Alpha
- 2 months ago - Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript - Seeking Alpha